Demographic data reveals that GLP-1 use spans age groups 1880+, though adoption is highest among adults aged 3055 with health insurance coverage
The practical lesson: higher doses do not always mean better outcomes when you factor in tolerability
Jastreboff AM, Ryan DH, Bays HE, et al
In vitro studies confirm that linagliptin suppresses the proliferation of several tumor cell lines, including colorectal cancer HCT116, breast cancer MCF-7, and liver cancer HepG2, via mechanisms that involve cell cycle arrest and apoptosis induction [96]
Li C, Ostermann T, Hardt M, Ldtke R, Broecker-Preuss M, Dobos G, Michalsen A: Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome